ABUS Stock Analysis: Buy, Sell, or Hold?
ABUS - Arbutus Biopharma Corporation Common Stock
$5.20
-0.01 (-0.19%)
▼
5d:
+10.4%
30d:
+18.72%
90d:
+19.54%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When ABUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ABUS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ABUS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABUS is currently trading at $5.20, which is considered extended relative to its 30-day fair value range of $4.36 to $4.83.
Technical Outlook: Technically, ABUS is in a uptrend. Immediate support is located at $4.42, while resistance sits at $5.45.
Market Sentiment: ABUS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABUS is in a uptrend. Immediate support is located at $4.42, while resistance sits at $5.45.
Market Sentiment: ABUS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.36 -
$4.83
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
15.8%
Protect Your Profits
Holding ABUS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($5.54)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.36 -
$4.83
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.42
Resistance Level
$5.45
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-46.85
Wall Street Target
$5.54
(+6.6%)
Revenue Growth (YoY)
-90.6%
Profit Margin
84.2%
Share & Embed Analysis
Last updated: August 25, 2026 3:50 AM ET
Data refreshes hourly during market hours. Next update: 4:50 AM
Data refreshes hourly during market hours. Next update: 4:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 65 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 38 SELL |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 39 SELL |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 34 SELL |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 41 HOLD |
Advanced ABUS Option Strategies
Professional options setups generated by AI based on today's ABUS price and gamma walls.
